tarextumab (OMP-59R5) - MorphoSys, Mereo Biopharma, GSK
OncoMed: Jefferies Global Healthcare Conference (OncoMed) - Jun 12, 2014 - Anticipated initiation of P2 portion of P1/2 ALPINE trial for pancreatic cancer in H2 2014; Anticipated initiation of P2 portion of P1/2 PINNACLE trial for small cell lung cancer in H2 2014  
Anticipated new P2 trial Oncology • Pancreatic Cancer
http://wsw.com/webcast/jeff82/omed/
 
Jun 12, 2014
 
.
 
b6351cae-7283-4433-a1bf-c485dd66c2f7.jpg